Brought to you by 
NPS Pharm. & SmithKline Beecham in osteoporosis tie-up; end deal to pursue expanded alliance
05 Aug 2011
Executive Summary
NPS Pharmaceuticals (ion-related drug targets, formerly Natural Product Sciences Inc.) and SmithKline Beecham have agreed to collaborate to discover and bring to market osteoporosis drugs based on NPS's work in calcium receptors.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Terminated
Deal Type
-
Alliance
- Co-Promotion
- Includes Contract
- Includes Equity
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
NPS Pharm. & SmithKline Beecham in osteoporosis tie-up; end deal to pursue expanded alliance
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice